Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypersensitivity | 19 | 2021 | 1137 | 3.07 | Why? |
| Desensitization, Immunologic | 15 | 2021 | 574 | 1.96 | Why? |
| Asthma | 20 | 2021 | 4383 | 1.55 | Why? |
| Rhinitis, Allergic | 14 | 2021 | 704 | 1.53 | Why? |
| Food Hypersensitivity | 3 | 2018 | 397 | 1.06 | Why? |
| Precision Medicine | 7 | 2020 | 1477 | 0.96 | Why? |
| Drug Hypersensitivity | 2 | 2018 | 401 | 0.94 | Why? |
| Lolium | 1 | 2019 | 2 | 0.83 | Why? |
| Anaphylaxis | 5 | 2021 | 940 | 0.70 | Why? |
| Rhinitis | 6 | 2021 | 626 | 0.65 | Why? |
| Allergens | 8 | 2019 | 728 | 0.63 | Why? |
| Sinusitis | 4 | 2021 | 649 | 0.43 | Why? |
| TRPA1 Cation Channel | 2 | 2021 | 82 | 0.42 | Why? |
| Academies and Institutes | 4 | 2020 | 539 | 0.36 | Why? |
| Histamine H1 Antagonists | 2 | 2019 | 79 | 0.35 | Why? |
| Immunotherapy | 2 | 2019 | 2421 | 0.35 | Why? |
| NF-E2-Related Factor 2 | 2 | 2021 | 373 | 0.33 | Why? |
| Genotype | 1 | 2019 | 4697 | 0.32 | Why? |
| Practice Guidelines as Topic | 7 | 2018 | 15421 | 0.27 | Why? |
| Mobile Applications | 5 | 2019 | 3032 | 0.25 | Why? |
| Sublingual Immunotherapy | 2 | 2020 | 88 | 0.24 | Why? |
| Allergists | 2 | 2021 | 266 | 0.24 | Why? |
| Biological Products | 4 | 2021 | 2331 | 0.23 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.23 | Why? |
| TRPV Cation Channels | 1 | 2021 | 88 | 0.20 | Why? |
| Phenotype | 4 | 2020 | 4037 | 0.20 | Why? |
| Mometasone Furoate, Formoterol Fumarate Drug Combination | 1 | 2018 | 1 | 0.20 | Why? |
| Spices | 1 | 2020 | 130 | 0.20 | Why? |
| Nasal Provocation Tests | 1 | 2018 | 12 | 0.19 | Why? |
| Antigens, Plant | 1 | 2018 | 40 | 0.18 | Why? |
| Europe | 7 | 2020 | 12702 | 0.18 | Why? |
| Information Technology | 1 | 2021 | 278 | 0.18 | Why? |
| Bee Venoms | 1 | 2017 | 43 | 0.17 | Why? |
| Technology, Pharmaceutical | 1 | 2018 | 82 | 0.17 | Why? |
| Conjunctivitis, Allergic | 1 | 2017 | 94 | 0.16 | Why? |
| One Health | 1 | 2021 | 390 | 0.15 | Why? |
| Humans | 61 | 2022 | 930598 | 0.15 | Why? |
| Work Performance | 1 | 2017 | 186 | 0.15 | Why? |
| Immunoglobulin E | 4 | 2020 | 557 | 0.15 | Why? |
| Anti-Allergic Agents | 1 | 2017 | 167 | 0.14 | Why? |
| Common Cold | 1 | 2021 | 645 | 0.14 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.13 | Why? |
| Respiratory Function Tests | 2 | 2017 | 1755 | 0.13 | Why? |
| Bronchodilator Agents | 1 | 2018 | 444 | 0.13 | Why? |
| Nasal Mucosa | 2 | 2018 | 1218 | 0.12 | Why? |
| Decision Support Systems, Clinical | 1 | 2018 | 551 | 0.12 | Why? |
| Multimorbidity | 1 | 2018 | 703 | 0.12 | Why? |
| Vaccines | 2 | 2021 | 3692 | 0.12 | Why? |
| Patient Participation | 1 | 2018 | 829 | 0.11 | Why? |
| Double-Blind Method | 2 | 2019 | 5988 | 0.11 | Why? |
| Advisory Committees | 1 | 2018 | 1418 | 0.10 | Why? |
| Self Care | 1 | 2018 | 918 | 0.10 | Why? |
| Symptom Assessment | 3 | 2019 | 4967 | 0.10 | Why? |
| Internet | 2 | 2018 | 6204 | 0.10 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.09 | Why? |
| Child | 9 | 2021 | 70012 | 0.09 | Why? |
| Visual Analog Scale | 2 | 2019 | 151 | 0.09 | Why? |
| Diet | 1 | 2020 | 2052 | 0.09 | Why? |
| Adrenal Cortex Hormones | 3 | 2021 | 6537 | 0.09 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.08 | Why? |
| Plant Extracts | 1 | 2018 | 1514 | 0.08 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.08 | Why? |
| Patient Care Team | 1 | 2021 | 3556 | 0.08 | Why? |
| Delivery of Health Care, Integrated | 1 | 2017 | 1549 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Administration, Intranasal | 2 | 2020 | 1132 | 0.07 | Why? |
| Periodicals as Topic | 1 | 2017 | 1492 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.07 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.06 | Why? |
| Population Surveillance | 2 | 2017 | 4967 | 0.06 | Why? |
| Evidence-Based Practice | 2 | 2018 | 693 | 0.06 | Why? |
| Triage | 1 | 2021 | 7151 | 0.06 | Why? |
| Brassica | 1 | 2021 | 66 | 0.05 | Why? |
| User-Computer Interface | 2 | 2018 | 1068 | 0.05 | Why? |
| Antioxidants | 2 | 2021 | 1593 | 0.05 | Why? |
| Fermentation | 1 | 2020 | 156 | 0.05 | Why? |
| Chronic Disease | 3 | 2021 | 5139 | 0.05 | Why? |
| Epinephrine | 1 | 2021 | 323 | 0.05 | Why? |
| Clinical Decision-Making | 3 | 2017 | 3755 | 0.05 | Why? |
| Mometasone Furoate | 1 | 2018 | 37 | 0.05 | Why? |
| Disease Resistance | 1 | 2020 | 236 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| Vegetables | 1 | 2020 | 340 | 0.04 | Why? |
| Nasal Polyps | 1 | 2021 | 221 | 0.04 | Why? |
| Quality of Life | 4 | 2021 | 9820 | 0.04 | Why? |
| Nasal Obstruction | 1 | 2018 | 131 | 0.04 | Why? |
| Presenteeism | 1 | 2017 | 63 | 0.04 | Why? |
| Sneezing | 1 | 2018 | 173 | 0.04 | Why? |
| Skin Tests | 1 | 2018 | 229 | 0.04 | Why? |
| United States | 3 | 2018 | 46150 | 0.04 | Why? |
| Bacterial Infections | 1 | 2010 | 2229 | 0.04 | Why? |
| International Classification of Diseases | 1 | 2019 | 265 | 0.04 | Why? |
| Cost-Benefit Analysis | 2 | 2017 | 2259 | 0.04 | Why? |
| Th2 Cells | 1 | 2020 | 680 | 0.04 | Why? |
| Smartphone | 2 | 2018 | 1840 | 0.04 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.04 | Why? |
| Economics, Pharmaceutical | 1 | 2016 | 61 | 0.04 | Why? |
| Pruritus | 1 | 2018 | 215 | 0.04 | Why? |
| Biological Factors | 1 | 2019 | 276 | 0.04 | Why? |
| Nasal Sprays | 1 | 2018 | 234 | 0.04 | Why? |
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 121 | 0.04 | Why? |
| Efficiency | 1 | 2019 | 420 | 0.04 | Why? |
| Disease Management | 3 | 2018 | 6841 | 0.04 | Why? |
| Absenteeism | 1 | 2017 | 287 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2017 | 647 | 0.04 | Why? |
| World Health Organization | 2 | 2019 | 4213 | 0.04 | Why? |
| Symptom Flare Up | 1 | 2018 | 432 | 0.04 | Why? |
| Reactive Oxygen Species | 1 | 2020 | 1136 | 0.03 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.03 | Why? |
| Medical Records | 1 | 2017 | 513 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Dysbiosis | 1 | 2020 | 685 | 0.03 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.03 | Why? |
| Consensus | 2 | 2021 | 6345 | 0.03 | Why? |
| Eosinophils | 1 | 2020 | 848 | 0.03 | Why? |
| Patient Outcome Assessment | 1 | 2018 | 707 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Argentina | 1 | 2017 | 1141 | 0.03 | Why? |
| Virus Diseases | 1 | 2010 | 3779 | 0.03 | Why? |
| Belgium | 1 | 2019 | 2064 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.03 | Why? |
| Health Plan Implementation | 1 | 2017 | 571 | 0.03 | Why? |
| Appointments and Schedules | 1 | 2020 | 1204 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Adult | 5 | 2021 | 244371 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Immune Tolerance | 1 | 2016 | 608 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Medication Adherence | 1 | 2020 | 1270 | 0.03 | Why? |
| Primary Prevention | 1 | 2017 | 778 | 0.03 | Why? |
| Oxidative Stress | 1 | 2021 | 2050 | 0.02 | Why? |
| Respiratory Tract Infections | 1 | 2010 | 6817 | 0.02 | Why? |
| Congresses as Topic | 1 | 2019 | 1347 | 0.02 | Why? |
| Animals | 4 | 2021 | 78931 | 0.02 | Why? |
| Geriatric Assessment | 1 | 2017 | 1372 | 0.02 | Why? |
| Aftercare | 1 | 2018 | 1637 | 0.02 | Why? |
| Young Adult | 4 | 2019 | 93724 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Clinical Competence | 1 | 2019 | 3263 | 0.02 | Why? |
| Research | 1 | 2017 | 2115 | 0.02 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2018 | 3419 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Germany | 1 | 2018 | 9196 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Male | 5 | 2021 | 367725 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Healthcare Disparities | 1 | 2017 | 3893 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2019 | 88759 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.01 | Why? |
| Telemedicine | 2 | 2020 | 25032 | 0.01 | Why? |
| Acute Disease | 1 | 2010 | 6029 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.01 | Why? |
| Female | 4 | 2019 | 380317 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Middle Aged | 3 | 2019 | 270681 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2022 | 51949 | 0.01 | Why? |
Agache's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(487)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_